(Q44470253)

English

A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

metastatic adenocarcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Steven R Alberts

4

object named as

Steven R Alberts

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

author name string

Aminah Jatoi

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Marisa Tria Tirona

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Steven S Cha

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Kendrith M Rowland

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Roscoe F Morton

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Suresh Nair

7

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Carl G Kardinal

8

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Philip J Stella

9

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

James A Mailliard

10

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Daniel Sargen

11

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Richard M Goldberg

12

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

International Journal of Gastrointestinal Cancer

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

2-3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

115-123

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: results of a phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12794247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Esophageal cancer. Facts, figures, and screening

1 reference

https://pubmed.ncbi.nlm.nih.gov/12794247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12794247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/12794247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12794247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid reporting and review of an increased incidence of a known adverse event

1 reference

https://pubmed.ncbi.nlm.nih.gov/12794247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/12794247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outpatient 5-fluorouracil, folinic acid and cisplatin in patients with advanced esophageal carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12794247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective quality-of-life analysis after palliative photoablation for the treatment of malignant dysphagia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12794247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction

1 reference

https://pubmed.ncbi.nlm.nih.gov/12794247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: preliminary evidence of clinical activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/12794247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design

1 reference

https://pubmed.ncbi.nlm.nih.gov/12794247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1385/IJGC:32:2-3:115

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44470253&oldid=2024962981"